Key Quantitative Figures
The company has allotted 4,45,86,052 equity shares under the scheme of amalgamation.
Dates of Action
The allotment was previously intimated on August 01, 2026. The shares have been listed and admitted to dealings on the National Stock Exchange of India Limited and BSE Limited with effect from September 23, 2026. The disclosure was digitally signed on September 23, 2026, at 19:52:21 +05'30'.
Parties Involved
The scheme of amalgamation was sanctioned by the Hon'ble National Company Law Tribunal, Chennai Bench (NCLT). The disclosure is signed by Kapil Dayya, Company Secretary & Compliance Officer (Membership No.: F10698) on behalf of Orchid Pharma Limited.
Financial Impact
No specific financial impact quantification is provided in the disclosure.
Capital Structure Impact
The issuance of 4,45,86,052 equity shares represents a material change to the company's capital structure, though specific pre- and post-issuance share capital figures are not disclosed.